在试验室中使用机械化纳米粒子的磁性激活进行药物分子的非侵入性远程控制释放
Courtney R Thomas1, Daniel P Ferris, Jae-Hyun Lee
1Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095-1569, USA.
Journal of the American Chemical Society
|August 5, 2010
概括
这项研究引入了用于向药物输送的新型磁性中等孔化纳米粒子. 外部磁场触发化学疗法药物的受控释放,证明了对乳腺癌细胞的有效性.
科学领域:
- 纳米技术纳米技术
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
背景情况:
- 半孔纳米粒子 (MSN) 是用于控制货物释放的多功能载体.
- 磁纳米粒子在交替的磁场下产生热量 (超热).
- 将这些组合在一起,为外部触发的药物输送系统提供了潜力.
研究的目的:
- 开发一种新的药物输送系统,使用嵌入MSN的磁纳米粒子.
- 为控制药物释放设计一个热敏的守门员机制.
- 为了评估这个系统对乳腺癌细胞的疗效.
主要方法:
- 在一个半孔框架内合成配合的氧化铁纳米晶体.
- 表面修改了纳米颗粒与伪托克萨恩守门员.
- 装载了多克索鲁比辛作为治疗货物.
- 应用了交流电 (AC) 磁场来诱导加热和药物释放.
- 在MDA-MB-231乳腺癌细胞上测试了该系统.
主要成果:
- 在AC磁场应用后,复合纳米粒子成功封装并释放了多克索鲁比辛.
- 磁纳米颗粒的局部加热引发了门卫的拆卸.
- 经过治疗的乳腺癌细胞在暴露于含药物颗粒和磁场时显示出显著的细胞死亡.
结论:
- 成功开发了一种新的,外部控制的药物输送系统.
- 该系统利用磁热过热来触发货物释放.
- 这种方法显示了作为乳腺癌的非侵入性治疗的希望.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

